Applications published 21 May 2007

Phenytoin formulations, and uses thereof in wound healing
Royal College of Surgeons in Ireland 1786397*

Testosterone gels comprising propylene glycol as penetration enhancer
Laboratoires Beins International 1786398*

A suspension comprising an active principle, a suspending vehicle, a density-modifying solid with an increased physical stability
Alza 1786399*

Pharmaceutical compsns for controlled release delivery of biologically active compounds
Quest Pharmaceutical Services 1786400*

Fast release compsn including melt granules of a moisture sensitive drug and process for manufacturing thereof
Novartis 1786401*

Controlled release delivery system for bio-active agents
KU Leuven Research & Development 1786402*

Oral dosage form safeguarded against abuse containing (1R, 2R)-3-(3-dimethylamino)-1-ethy;-2-methyl-propyl)-phenol
Gruenenthal 1786403*

Opioid dosage forms having dose proportional steady state cave and AUC and less than dose proportional single dose CMAX
Euro-Celtique 1786404*

Compounds and methods for controlling alcohol intake
Colombani, Jean-Noel 1786405*

Skin coating compsn and uses thereof
Blonde Holdings 1786406*

Use of vitamin DS to treat kidney disease
Abbott Laboratories 1786407*

Use of a selective estrogen receptor modulator for the manufacture of a pharmaceutical preparation for use in a method for the treatment or prevention of androgen deficiency
Hormos Medical 1786408*

Wound healing
Ethicon 1786409*

The treatment of inflammatory disorders and pain
Sosei R&D 1786410*

3-halo-2-oxopropionate salts and esters as novel anticancer agents
Board of Regents, The University of Texas System 1786411*

Arene ruthenium (II) compounds and their use in cancer therapy
The University Court of the University of Edinburgh 1786412*

Antimicrobial elastomer compsn and method for making
Helix Medical 1786413*

Novel statin pharmaceutical compsns and related methods of treatment
Transform Pharmaceuticals 1786414*

Metabolism-modulating agents and uses therefor
The University of Queensland 1786415*

Sulpiride derivatives pharmaceutical compsns
Barbeau Pharma 1786416*

Novel polymorphs of azabicyclohexane
DOV Pharmaceutical 1786417*

Methods of treating proliferative skin diseases using carbazole derivatives
Cephalon 1786418*

Derivatives or aryl (or heteroaryl) azolylcarbonols (in particular cizolirtin citrate) for the treatment of opioid addiction
Laboratoires del Dr Esteve 1786419*

Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of central neuropathic pain
Laboratoires del Dr Esteve 1786420*

Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases
Cengent Therapeutics 1786421*

Aryl urea derivatives for treating obesity
Prosidion 1786422*

A pharmaceutical compsn for treating ataxia, multiple system atrophy or balance disorders
Shionogi 1786423*

Lonidamine analogues and their use in male contraception and cancer treatment
The University of Kansas; University of Kansas Medical Centre 1786424*

Useful compounds for HPV infection
SmithKline Beecham 1786425*

Soluble amide and ester pyrazinoyl-guanidine sodium channel blockers
Parion Sciences 1786426*

Aliphatic amide and ester pyrazinoyl-guanidine sodium channel blockers
Jonson, Michael R 1786427*

PDE5 inhibitor compsns and methods for treating cardiac indications
The Johns Hopkins University 1786428*

Compsns and methods relating to novel compounds and targets thereof
The Regents of the University of Michigan 1786429*

Small molecules that replace or agonise P53 function
Buck Institute for Age Research 1786430*

Improved photosensitiser formulations and their use
Ceramoptec Industries 1786431*

Arrangement for the removal for an absorbent article from a stack of absorbent articles
Synphora 1786432*

Betulinol derivatives as anti-HIV agents
Cornell Research Foundation 1786433*

Insecticidal compsns
SRM 1786434*

Compn therapies employing vitamin B6 related compounds and ACE inhibitors and uses thereof for the treatment of diabetic disorders
Medicure International 1786435*

Method for improving ventilatory efficiency
Bioenergy; MacCarter, Dean; St Cyr, John 1786436*

Improved GHB compsns
Orphan Medical 1786437*

Method for increasing the bone mineral density and bone architecture or connectivity of a mammal using N-acylated glucosamines
Anastassiades, Tassos 1786438*

Methods of activating NKT cells
The University of Chicago; The Scripps Research Institute; Brigham Young University 1786439*

Treatments of refractory cancers using NA+/K+-ATPase inhibitors
Bionaut Pharmaceuticals 1786440*

Method and means for enhanced pulmonary drug delivery
University College Cardiff Consultants 1786441*

Treatment of neurodegenerative diseases by the use of DEGS inhibitors
Cellzome 1786442*

Particulate constructs for the release of active agents
Celator Pharmaceuticals; The Trustees of Princeton University 1786443*

Intradiscal production of autologous interleukin receptor antagonist
DuPuy Spine 1786444*

Live microbial microbicides
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1786445*

Topical phytotherapeutic compound for the treatment of herpes based in Uncaria tomentosa and extraction process for obtaining a vegetal extract from Uncaria tomentosa
Herbarium Labatorio Botanico LTDA 1786446*

Method for producing a ginger fraction and the use thereof for inhibiting human CYP enzymes
Boehringer Ingelheim International 1786447*

Use of GSK-3 inhibitors for the treatment of prostate cancer
Imperial Innovations 1786448*

Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
Active Biotech 1786449*

HIV immunostimulatory compsns
3M Innovative Properties 1786450*

Anti-angiogenic peptides and methods of use thereof
Sopherion Therapeutics 1786451*

Use of DM43 and its fragments as matrix metalloproteinases inhibitor
Fundo ao Oswaldo Cruz-Fiocruz 1786452*

Alpha-defensins as anthrax immunotherapeutics
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1786453*

Neublastin variants
Biogen Idec 1786454*

Use of intradiscally administered autologous cells producing type 1 interferon for the treatment of degenerative disc disease
DePuy Spine 1786455*

Use of APO2L receptor agonists and NK cells or NK cell activators
Genentech 1786456*

Use of IL-6 in vascular complications
Applied Research Systems 1786457*

Y2/Y4 selective receptor agonists for therapeutic interventions
7TM Pharma 1786458*

Therapeutic compsn with a botulinum neurotoxin
Merz Pharma 1786459*

Assay for detecting tuberculosis in nonhuman primates
Sequella; Chembio Diagnostic Systems 1786460*

Antibiotic resistance free DNA vaccines
The Trustees of the University of Pennsylvania 1786461*

Use of parasitic biological agents for prevention and control of allergic and ther IGE-mediated disorders
Milestone Research 1786462*

Antibodies against NOGO receptor
Human Genome Sciences 1786463*

Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
Alexion Pharmaceuticals 1786464*

Methods for detecting and treating autoimmune disorders
Oregon Health Science University; The Government of the United States of America, as represented by the Department of Veterans" Affairs; The Immune Response Corp 1786465*

Combination of a chemotherapeutic agent and an antagonist of a gene product for treating tumours
Genentech 1786466*

Method of enhancing absorptions of transmucosal administration formulations
The Chinese University of Hong Kong 1786467*

Compsn for promoting vascular smooth muscle relaxation
Futura Medical Developments 1786468*

Humanised anti-5T4 antibodies and anti-5T4 antibody/calicheamicin conjugates
Wyeth 1786469*

Nucleic acid constructs and cells, and methods utilising same for modifying the electrophysiological function of excitable tissues
GeneGrafts 1786470*

Treating cardiovascular tissue
Mayo Foundation for Medical Education and Research 1786471*

Antisense modulation of apolipoprotein B expression
Isis Pharmaceuticals 1786472*

Treatment of Parkinson's disease and related disorders
Cedars-Sinai Medical Centre 1786473*

Combined gene therapy for the treatment of microscopic gliomas
Cedars-Sinai Medical Centre 1786474*